Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.6450 (7.75%) ($7.6450 - $7.6450) on Sat. Aug. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 58 | Latest Price | $7.6450(7.75%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -0.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BCRX price | BCRX will decline at least -1.385% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.22(5.89%) | 10 Day Moving Average | $7.43(2.89%) | 20 Day Moving Average | $7.36(3.87%) | To recent high | -13.7% | To recent low | 10.2% | Market Cap | $N/A | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |